Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

scNMT-seq Allows Analysis of Connections Between Nucleosomes, Methylation and Transcription

News

A new bioinformatics technique allows researchers to study three key processes inside the cell simultaneously.

READ MORE

CRISPR Study Reveals Errors in Earlier Cancer Research

News

MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.

READ MORE

Microscopic Movie Shows How DNA Gets in Shape

News

DNA is folded into loops by a protein called condensin, and the process has been filmed for the first time.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE